TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
TSHA

Taysha Gene Therapies Inc

Healthcare · Biotechnology · —

4.80$ -2.4% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Income Statement

All figures per share in USD.

Tick rows to compare them in a chart (up to 4)

Income Statement TSHA
Line item 2019 2020 2021 2022 2023 2024 2025
– 0.00 0.00 0.06 0.13 0.03 0.03
– 0.00 0.01 0.06 0.01 0.00 0.00
– 0.00 -0.01 0.00 0.13 0.03 0.03
0.03 1.81 3.50 2.07 0.49 0.26 0.27
0.01 0.63 1.10 0.85 0.26 0.12 0.11
0.03 2.43 4.60 2.87 0.76 0.40 0.38
-0.03 -2.43 -4.60 -2.87 -0.62 -0.37 -0.35
0.00 0.00 0.04 0.09 0.04 0.00 0.00
-0.03 -3.40 -4.64 -3.78 -0.96 -0.36 -0.34
-0.12 -0.96 0.02 0.08 0.01 -0.36 –
-0.03 -2.43 -4.64 -3.78 -0.96 -0.36 -0.34
-0.03 -3.39 -4.58 -3.63 -0.91 -0.35 -0.34

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?